Annual Working Capital
$603.45 M
+$84.71 M+16.33%
December 31, 2024
Summary
- As of March 10, 2025, APLS annual working capital is $603.45 million, with the most recent change of +$84.71 million (+16.33%) on December 31, 2024.
- During the last 3 years, APLS annual working capital has fallen by -$88.75 million (-12.82%).
- APLS annual working capital is now -23.50% below its all-time high of $788.87 million, reached on December 31, 2020.
Performance
APLS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$603.45 M
-$39.19 M-6.10%
December 31, 2024
Summary
- As of March 10, 2025, APLS quarterly working capital is $603.45 million, with the most recent change of -$39.19 million (-6.10%) on December 31, 2024.
- Over the past year, APLS quarterly working capital has stayed the same.
- APLS quarterly working capital is now -38.37% below its all-time high of $979.21 million, reached on March 31, 2022.
Performance
APLS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
APLS Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +16.3% | 0.0% |
| 3 y3 years | -12.8% | -12.8% |
| 5 y5 years | +96.3% | -12.8% |
APLS Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -12.8% | +16.3% | -38.4% | +16.3% |
| 5 y | 5-year | -23.5% | +96.3% | -38.4% | +96.3% |
| alltime | all time | -23.5% | >+9999.0% | -38.4% | +5428.5% |
Apellis Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $603.45 M(+16.3%) | $603.45 M(-6.1%) |
| Sep 2024 | - | $642.64 M(-7.0%) |
| Jun 2024 | - | $690.81 M(+15.9%) |
| Mar 2024 | - | $596.14 M(+14.9%) |
| Dec 2023 | $518.74 M(-6.0%) | $518.74 M(-15.1%) |
| Sep 2023 | - | $611.14 M(-14.9%) |
| Jun 2023 | - | $717.85 M(-12.0%) |
| Mar 2023 | - | $815.61 M(+47.8%) |
| Dec 2022 | $551.91 M(-20.3%) | $551.91 M(-23.0%) |
| Sep 2022 | - | $716.49 M(-14.0%) |
| Jun 2022 | - | $833.18 M(-14.9%) |
| Mar 2022 | - | $979.21 M(+41.5%) |
| Dec 2021 | $692.20 M(-12.3%) | $692.20 M(+81.6%) |
| Sep 2021 | - | $381.19 M(-23.4%) |
| Jun 2021 | - | $497.34 M(-27.9%) |
| Mar 2021 | - | $689.96 M(-12.5%) |
| Dec 2020 | $788.87 M | $788.87 M(+18.3%) |
| Sep 2020 | - | $667.08 M(-16.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $795.84 M(+28.0%) |
| Mar 2020 | - | $621.67 M(+102.3%) |
| Dec 2019 | $307.34 M(+65.8%) | $307.34 M(-24.4%) |
| Sep 2019 | - | $406.62 M(+49.0%) |
| Jun 2019 | - | $272.82 M(-6.0%) |
| Mar 2019 | - | $290.14 M(+56.5%) |
| Dec 2018 | $185.41 M(+5.7%) | $185.41 M(-16.8%) |
| Sep 2018 | - | $222.90 M(-13.1%) |
| Jun 2018 | - | $256.45 M(+64.6%) |
| Mar 2018 | - | $155.79 M(-11.2%) |
| Dec 2017 | $175.46 M(+639.4%) | $175.46 M(+1350.7%) |
| Sep 2017 | - | $12.10 M(-76.0%) |
| Jun 2017 | - | $50.45 M(+112.6%) |
| Dec 2016 | $23.73 M(-31.9%) | $23.73 M(-31.9%) |
| Dec 2015 | $34.84 M(+164.7%) | $34.84 M(+219.2%) |
| Sep 2015 | - | $10.92 M(-29.3%) |
| Jun 2015 | - | $15.44 M(+17.3%) |
| Dec 2014 | $13.17 M(+191.7%) | $13.17 M |
| Dec 2013 | $4.51 M | - |
FAQ
- What is Apellis Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual working capital year-on-year change?
- What is Apellis Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly working capital year-on-year change?
What is Apellis Pharmaceuticals annual working capital?
The current annual working capital of APLS is $603.45 M
What is the all time high annual working capital for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual working capital is $788.87 M
What is Apellis Pharmaceuticals annual working capital year-on-year change?
Over the past year, APLS annual working capital has changed by +$84.71 M (+16.33%)
What is Apellis Pharmaceuticals quarterly working capital?
The current quarterly working capital of APLS is $603.45 M
What is the all time high quarterly working capital for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly working capital is $979.21 M
What is Apellis Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, APLS quarterly working capital has changed by $0.00 (0.00%)